IP Library Granted Patent US 7,915,392
Granted Patent B2
US 7,915,392 · App. 12/138,673 · Granted Mar 29, 2011

5-bromo-2′-deoxy-uridine labeled nucleotide triphosphates and nucleic acid probes and methods of making and using the same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,915,392
App. No.
12/138,673
Granted
Mar 29, 2011
Kind
B2
Abstract

5-bromo-2′-deoxy-uridine (BrdU) labeled nucleotide triphosphates and nucleic acid probes are described herein. The BrdU labeled nucleotide triphosphates include a linker between the nucleotide triphosphate and the BrdU moiety. The linker can be cleavable or non-cleavable. The nucleotide triphosphates can be a ribonucleotide triphosphates, 2′-deoxyribonucleotide triphosphates or 2′,3′-dideoxyribonucleotide triphosphates. The nucleic acid probes can be used for in situ hybridization.

Claims (43)

1. A compound of the formula:

or a salt thereof, wherein “Nu” is a nucleotide triphosphate, a 2′-deoxynucleotide triphosphate or a 2′,3′-dideoxynucleotide triphosphate and wherein L is a linker.

2. The compound of claim 1 , wherein L has a length greater than a C 11 n-alkane carbon chain.

3. The compound of claim 1 , wherein “Nu” is uridine triphosphate, 2′-deoxyuridine triphosphate or 2′,3′-dideoxyuridine triphosphate.

4. The compound of claim 1 , wherein the compound is of the formula:

or a salt thereof, wherein each X is independently H or OH and “L” is a linker.

5. The compound of claim 1 , wherein “L” is a linker having a chemical structure selected from the group consisting of:

wherein n is an integer of from 6 to 12.

6. The compound of claim 1 , wherein the compound is of the formula:

or a salt thereof, wherein each X is independently H or OH.

7. A polynucleotide represented by the formula:

wherein “Y” is a nucleoside, a nucleotide or a polynucleotide, “Z” is H, a nucleotide or a polynucleotide, “X” is H or OH, “B” is a nucleobase and “L” is a linker.

8. The polynucleotide of claim 7 , wherein the polynucleotide is represented by the formula:

wherein “Y” is a nucleoside, nucleotide or polynucleotide, “Z” is H, a nucleotide or a polynucleotide, “X” is H or OH and “L” is a linker.

9. The polynucleotide of claim 7 , wherein “L” is a linker having a chemical structure selected from the group consisting of:

wherein n is an integer of from 6 to 12.

10. A polynucleotide represented by the formula:

wherein “Y” is a nucleoside, nucleotide or polynucleotide, “Z” is H, a nucleotide or a polynucleotide and “X” is H or OH.

11. A method for detecting the presence of a nucleic acid analyte in a tissue sample comprising:

incubating the tissue sample with a composition comprising the polynucleotide of claim 7 , wherein the polynucleotide binds to the nucleic acid analyte;

washing the sample;

contacting the sample with an anti-BrdU antibody conjugated to a detectable moiety or to an enzyme; and

detecting the detectable moiety or enzyme.

12. A composition comprising:

adenosine triphosphate (ATP);

uridine triphosphate (UTP);

guanosine triphosphate (GTP);

cytidine triphosphate (CTP); and

a compound as set forth in claim 1 , wherein “Nu” is a nucleotide triphosphate.

13. A kit comprising:

a composition as set forth in claim 12 ; and

an RNA polymerase.

14. A composition comprising:

dATP, dCTP, dGTP, dTTP and a compound as set forth in claim 1 , wherein “Nu” is a 2′-deoxynucleotide triphosphate or a 2′,3′-dideoxynucleotide triphosphate.

15. A kit comprising:

a composition as set forth in claim 14 , wherein “Nu” is a 2′-deoxynucleotide triphosphate; and

a DNA polymerase.

16. A kit comprising:

a composition as set forth in claim 14 , wherein “Nu” is a 2′,3′-dideoxynucleotide triphosphate; and

terminal transferase.

17. A sodium salt of the compound of claim 1 .

18. A sodium salt of the compound of claim 6 .

19. The method of claim 11 , wherein the sample comprises a fixed sample.

Assignments (5)
MERGER Recorded Jan 7, 2014
From: APPLERA CORPORATION
To: APPLIED BIOSYSTEMS INC.
Reel/Frame 031907/0542 →
MERGER Recorded Jan 7, 2014
From: ATOM ACQUISITION CORPORATION
To: APPLIED BIOSYSTEMS INC.
Reel/Frame 031907/0574 →
MERGER Recorded Jan 7, 2014
From: ATOM ACQUISITION CORPORATION; APPLIED BIOSYSTEMS INC.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 031907/0620 →
LIEN RELEASE Recorded Apr 9, 2013
From: BANK OF AMERICA, N.A.
To: APPLIED BIOSYSTEMS, INC.
Reel/Frame 030182/0677 →
SECURITY AGREEMENT Recorded Dec 5, 2008
From: APPLIED BIOSYSTEMS, LLC
To: BANK OF AMERICA, N.A, AS COLLATERAL AGENT
Reel/Frame 021976/0001 →